Literature DB >> 20813313

Sublobar resection for early-stage lung cancer.

Matthew J Schuchert1, Ghulam Abbas, Arjun Pennathur, Katie S Nason, David O Wilson, James D Luketich, Rodney J Landreneau.   

Abstract

The use of sublobar resection techniques (anatomic segmentectomy; extended wedge) in the treatment of early-stage non-small cell lung cancer has been associated with increased local recurrence rates compared with lobectomy. Recent data, however, have suggested that sublobar resection of smaller tumors (especially those < or =2 cm) can be performed with no significant difference in local recurrence or long-term survival. These findings have particular relevance in elderly patients and in those patients who may be at high risk for lobectomy because of underlying medical comorbidities. Careful patient selection on the basis of individualized assessment of specific patient and tumor characteristics will aid in selecting the optimal approach. For larger tumors, or when adequate surgical margins are not obtainable, lobectomy should be performed. Currently, active, prospective, randomized studies (Cancer and Leukemia Group B [CALGB] 140503 and American College of Surgeons Oncology Group [ACOSOG] Z4032) will provide critical insights in delineating the efficacy of sublobar resection techniques in early-stage non-small cell lung cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20813313     DOI: 10.1053/j.semtcvs.2010.04.004

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  10 in total

1.  Video-assisted thoracoscopic surgery right upper posterior segmentectomywith systemic mediastinal lymph node dissection.

Authors:  Lin Ma; Chengwu Liu; Lunxu Liu
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

2.  The lobar vs. sublobar "limited" resection respiratory function preservation debate: learning to speak the same language.

Authors:  Vasileios Kouritas; Richard Milton
Journal:  Ann Transl Med       Date:  2017-04

3.  Open, thoracoscopic and robotic segmentectomy for lung cancer.

Authors:  Chi-Fu Jeffrey Yang; Thomas A D'Amico
Journal:  Ann Cardiothorac Surg       Date:  2014-03

Review 4.  Sublobar resection for early-stage lung cancer.

Authors:  Hiroyuki Sakurai; Hisao Asamura
Journal:  Transl Lung Cancer Res       Date:  2014-06

5.  Preoperative 3-dimensional computed tomography lung simulation before video-assisted thoracoscopic anatomic segmentectomy for ground glass opacity in lung.

Authors:  Liang Xue; Hong Fan; Woda Shi; Di Ge; Yi Zhang; Qun Wang; Yunfeng Yuan
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

6.  Prediction of the Invasiveness of Ground-Glass Nodules in Lung Adenocarcinoma by Radiomics Analysis Using High-Resolution Computed Tomography Imaging.

Authors:  Tianqi Zhang; Xiuling Li; Jianhua Liu
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

7.  Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer.

Authors:  Anthony W Kim; Frank C Detterbeck; Daniel J Boffa; Roy H Decker; Pamela R Soulos; Laura D Cramer; Cary P Gross
Journal:  Ann Thorac Surg       Date:  2012-07-25       Impact factor: 4.330

8.  Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer.

Authors:  Hyun Woo Jeon; Young-Du Kim; Kyung Soo Kim; Sook Whan Sung; Hyung Joo Park; Jae Kil Park
Journal:  World J Surg Oncol       Date:  2014-07-16       Impact factor: 2.754

9.  Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non-small cell lung cancer tumors.

Authors:  Terrance Peng; Sean C Wightman; Li Ding; Dustin K Lieu; Scott M Atay; Elizabeth A David; Anthony W Kim
Journal:  JTCVS Open       Date:  2022-04-14

10.  Division of the intersegmental demarcation using the "modified hand-tearing method" is safe and feasible in thoracoscopic anatomical segmentectomy.

Authors:  Zhen Feng; Benchuang Hu; Shuliang Yu; Chenran Guo; Zhongmin Peng
Journal:  Thorac Cancer       Date:  2022-08-18       Impact factor: 3.223

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.